help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laughlin, G. A.
Right arrow Articles by Yen, S. S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laughlin, G. A.
Right arrow Articles by Yen, S. S. C.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 6 1692-1696
Copyright © 1997 by The Endocrine Society


Reproductive Endocrinology

Serum Leptin Levels in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance/ Hyperinsulinemia1

G. A. Laughlin, A. J. Morales and S. S. C. Yen2

Department of Reproductive Medicine, School of Medicine 0633, University of California, San Diego, La Jolla, California 92093-0633

Address all correspondence to: Samuel S. C. Yen, Department of Reproductive Medicine, School of Medicine 0633, University of California, 9500 Gilman Drive, La Jolla, California 92093-0633. Reprints not available.

Polycystic ovary syndrome (PCOS) is associated with chronic anovulation, hyperandrogenemia, insulin resistance (IR)/hyperinsulinemia, and a high incidence of obesity. Thus, PCOS serves as a useful model to assess the role of IR and chronic endogenous insulin excess on leptin levels. Thirty-three PCOS and 32 normally cycling (NC) women of similar body mass index (BMI) were studied. Insulin sensitivity (SI) was assessed by rapid ivGTT in a subset of 28 PCOS and 29 NC subjects; percent body fat was determined by dual-energy x-ray absorptiometry (DEXA) in 14 PCOS and 17 NC. Fasting (0800 h) and 24-h mean hourly insulin levels were 2-fold higher (P < 0.0001), and SI was 50% lower (P = 0.005) in PCOS than in NC, while serum androstenedione (A), testosterone (T), 17-{alpha} hydroxyprogesterone (17OHP), and estrone (E1) levels were elevated (P < 0.0001), and sex hormone-binding globulin (SHBG) levels were decreased (P < 0.01). Twenty-four hour LH pulse frequency, mean pulse amplitude, and mean LH levels were elevated in PCOS (P < 0.001) as compared with NC.

Serum leptin levels for PCOS (24.1 ± 2.6 ng/mL) did not differ from NC (21.5 ± 3.5 ng/mL) and were positively correlated with BMI (r = 0.81) and percent body fat (r = 0.91) for the two groups (both P < 0.0001). Leptin levels for PCOS and NC correlated positively with fasting and 24-h mean insulin levels (r = 0.81, P < 0.0001 for both PCOS and NC) and negatively with SI and SHBG levels. Leptin concentrations for PCOS, but not NC, correlated positively with 24-h mean glucose levels and inversely with 24-h mean LH levels and 24-h mean LH pulse amplitude. Leptin levels were not correlated with estrogen or androgen levels for either PCOS or NC, although leptin levels were positively related to the ratios of E1/SHBG and E2/SHBG for both PCOS and NC and to the ratio of T/SHBG for PCOS only. In stepwise multivariate regression with forward selection, only 24-h mean insulin levels contributed significantly (P < 0.01) to leptin levels independent of BMI and percent body fat for both PCOS and NC. Given this relationship and the presence of 2-fold higher 24-h mean insulin levels in PCOS, the expected elevation of leptin levels in PCOS was not found. This paradox may be explained by the presence of adipocyte IR specific to PCOS, which may negate the stimulatory impact of hyperinsulinemia on leptin secretion, a proposition requiring further study.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. A. Lawson, S. Jain, S. Sun, K. Patel, P. J. Malcolm, and R. J. Chang
Evidence for Insulin Suppression of Baseline Luteinizing Hormone in Women with Polycystic Ovarian Syndrome and Normal Women
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2089 - 2096.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Manneras, S. Cajander, A. Holmang, Z. Seleskovic, T. Lystig, M. Lonn, and E. Stener-Victorin
A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome
Endocrinology, August 1, 2007; 148(8): 3781 - 3791.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.K. Ludwig, J.M. Weiss, S. Tauchert, T. Dietze, S. Rudolf, K. Diedrich, A. Peters, and K.M. Oltmanns
Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome
Hum. Reprod., June 1, 2007; 22(6): 1555 - 1561.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. L. Pagan, S. S. Srouji, Y. Jimenez, A. Emerson, S. Gill, and J. E. Hall
Inverse Relationship between Luteinizing Hormone and Body Mass Index in Polycystic Ovarian Syndrome: Investigation of Hypothalamic and Pituitary Contributions
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1309 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S. Hahn, U. Haselhorst, B. Quadbeck, S. Tan, R. Kimmig, K. Mann, and O. E Janssen
Decreased soluble leptin receptor levels in women with polycystic ovary syndrome
Eur. J. Endocrinol., February 1, 2006; 154(2): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., G. Matarese, S. Di Biase, S. Palomba, D. Labella, V. Sanna, S. Savastano, F. Zullo, A. Colao, and G. Lombardi
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-{gamma} Polymorphisms in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5887 - 5892.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, S. M. Pincus, M. C. Garcia-Rudaz, M. G. Ropelato, M. E. Escobar, and M. Barontini
Disruption of the Synchronous Secretion of Leptin, LH, and Ovarian Androgens in Nonobese Adolescents with the Polycystic Ovarian Syndrome
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3772 - 3778.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P.M. Spritzer, M. Poy, D. Wiltgen, L.S. Mylius, and E. Capp
Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements
Hum. Reprod., July 1, 2001; 16(7): 1340 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
T. Laml, O. Preyer, B. W. Hartmann, E. Ruecklinger, G. Soeregi, and P. Wagenbichler
Decreased Maternal Serum Leptin in Pregnancies Complicated by Preeclampsia
Reproductive Sciences, April 1, 2001; 8(2): 89 - 93.
[Abstract] [PDF]


Home page
Hum ReprodHome page
C. S.Mantzoros, D. W.Cramer, R. F.Liberman, and R. L.Barbieri
Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome
Hum. Reprod., March 1, 2000; 15(3): 539 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Imani, M. J. C. Eijkemans, F. H. de Jong, N. N. Payne, P. Bouchard, L. C. Giudice, and B. C. J. M. Fauser
Free Androgen Index and Leptin Are the Most Prominent Endocrine Predictors of Ovarian Response during Clomiphene Citrate Induction of Ovulation in Normogonadotropic Oligoamenorrheic Infertility
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 676 - 682.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. L. Bützow, J. M. Moilanen, M. Lehtovirta, T. Tuomi, O. Hovatta, R. Siegberg, C.-G. Nilsson, and D. Apter
Serum and Follicular Fluid Leptin during in Vitro Fertilization: Relationship among Leptin Increase, Body Fat Mass, and Reduced Ovarian Response
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3135 - 3139.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Rosenbaum and R. L. Leibel
Role of Gonadal Steroids in the Sexual Dimorphisms in Body Composition and Circulating Concentrations of Leptin
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1784 - 1789.
[Full Text]


Home page
Hum ReprodHome page
T. Sir-Petermann, V. Piwonka, F. Perez, M. Maliqueo, S.E. Recabarren, and L. Wildt
Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome?
Hum. Reprod., June 1, 1999; 14(6): 1435 - 1439.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. S. Mantzoros
The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence
Ann Intern Med, April 20, 1999; 130(8): 671 - 680.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I.E. Messinis, S.D. Milingos, E. Alexandris, I. Kariotis, G. Kollios, and K. Seferiadis
Leptin concentrations in normal women following bilateral ovariectomy
Hum. Reprod., April 1, 1999; 14(4): 913 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. K. Agarwal, K. Vogel, S. R. Weitsman, and D. A. Magoffin
Leptin Antagonizes the Insulin-Like Growth Factor-I Augmentation of Steroidogenesis in Granulosa and Theca Cells of the Human Ovary
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1072 - 1076.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. C. Morin-Papunen, R. M. Koivunen, C. Tomás, A. Ruokonen, and H. K. Martikainen
Decreased Serum Leptin Concentrations during Metformin Therapy in Obese Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2566 - 2568.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Licinio, A. B. Negrao, C. Mantzoros, V. Kaklamani, M.-L. Wong, P. B. Bongiorno, A. Mulla, L. Cearnal, J. D. Veldhuis, J. S. Flier, et al.
Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women
PNAS, March 3, 1998; 95(5): 2541 - 2546.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Dunaif
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Endocr. Rev., December 1, 1997; 18(6): 774 - 800.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Karlsson, K. Lindell, E. Svensson, C. Bergh, P. Lind, H. Billig, L. M. S. Carlsson, and B. Carlsson
Expression of Functional Leptin Receptors in the Human Ovary
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4144 - 4148.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Arroyo, G. A. Laughlin, A. J. Morales, and S. S. C. Yen
Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3728 - 3733.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. F. Caro
Leptin Is Normal in PCOS, An Editorial about Three "Negative" Papers
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1685 - 1686.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society